IBU Fundamental Analysis - IBU-TEC ADVANCED MATERIALS A

Fundamental Rating

IBU gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 67 industry peers in the Chemicals industry. While IBU has a great health rating, there are worries on its profitability. IBU is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

IBU had negative earnings in the past year.

In the past year IBU had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: IBU reported negative net income in multiple years.

The reported operating cash flow has been mixed in the past 5 years: IBU reported negative operating cash flow in multiple years.

1.2 Ratios

IBU has a Return On Assets of -7.69%. This is in the lower half of the industry: IBU underperforms 76.81% of its industry peers.

IBU's Return On Equity of -10.32% is on the low side compared to the rest of the industry. IBU is outperformed by 71.01% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.69%
ROE	-10.32%
ROIC	N/A

ROA(3y)-3.09%

ROA(5y)-1.54%

ROE(3y)-4.18%

ROE(5y)-1.98%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of IBU (46.34%) is better than 66.67% of its industry peers.

IBU's Gross Margin has declined in the last couple of years.

IBU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	46.34%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.97%

GM growth 5Y-1.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IBU does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, IBU has about the same amount of shares outstanding.

Compared to 5 years ago, IBU has more shares outstanding

The debt/assets ratio for IBU has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.05 indicates that IBU is not a great score, but indicates only limited risk for bankruptcy at the moment.

IBU's Altman-Z score of 2.05 is in line compared to the rest of the industry. IBU outperforms 47.83% of its industry peers.

IBU has a debt to FCF ratio of 2.92. This is a good value and a sign of high solvency as IBU would need 2.92 years to pay back of all of its debts.

The Debt to FCF ratio of IBU (2.92) is better than 88.41% of its industry peers.

A Debt/Equity ratio of 0.13 indicates that IBU is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.13, IBU belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	2.92
Altman-Z	2.05

ROIC/WACCN/A

WACC6.72%

2.3 Liquidity

IBU has a Current Ratio of 7.42. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.

IBU has a better Current ratio (7.42) than 98.55% of its industry peers.

A Quick Ratio of 2.75 indicates that IBU has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 2.75, IBU belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.42
Quick Ratio	2.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IBU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.39%.

Looking at the last year, IBU shows a small growth in Revenue. The Revenue has grown by 4.93% in the last year.

Measured over the past years, IBU shows a small growth in Revenue. The Revenue has been growing by 0.88% on average per year.

EPS 1Y (TTM)-113.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%24.75%

Revenue 1Y (TTM)4.93%

Revenue growth 3Y4.71%

Revenue growth 5Y0.88%

Sales Q2Q%12.48%

3.2 Future

The Earnings Per Share is expected to grow by 31.58% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 14.73% on average over the next years. This is quite good.

EPS Next Y23.88%

EPS Next 2Y31.58%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year8.25%

Revenue Next 2Y14.73%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IBU. In the last year negative earnings were reported.

Also next year IBU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IBU is valued a bit more expensive than the industry average as 68.12% of the companies are valued more cheaply.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBU indicates a somewhat cheap valuation: IBU is cheaper than 79.71% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	13.09
EV/EBITDA	35.74

4.3 Compensation for Growth

A more expensive valuation may be justified as IBU's earnings are expected to grow with 31.58% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y31.58%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

IBU has a yearly dividend return of 0.18%, which is pretty low.

Compared to an average industry Dividend Yield of 3.00, IBU is paying slightly less dividend.

With a Dividend Yield of 0.18, IBU pays less dividend than the S&P500 average, which is at 2.44.

		Industry Rank	Sector Rank
Dividend Yield	0.18%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2Y31.58%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IBU-TEC ADVANCED MATERIALS A

FRA:IBU (6/19/2025, 7:00:00 PM)

6.42

0 (0%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)03-25 2025-03-25/amc

Earnings (Next)08-25 2025-08-25

Inst Owners3.82%

Inst Owner ChangeN/A

Ins Owners48.12%

Ins Owner ChangeN/A

Market Cap30.50M

Analysts45.71

Price Target7.75 (20.72%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.18%

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)2.7%

PT rev (3m)2.7%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.6
P/FCF	13.09
P/OCF	3.27
P/B	0.59
P/tB	0.65
EV/EBITDA	35.74

EPS(TTM)-1.12

EYN/A

EPS(NY)-1.03

Fwd EYN/A

FCF(TTM)0.49

FCFY7.64%

OCF(TTM)1.96

OCFY30.55%

SpS10.66

BVpS10.82

TBVpS9.88

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.69%
ROE	-10.32%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	46.34%
FCFM	4.6%

ROA(3y)-3.09%

ROA(5y)-1.54%

ROE(3y)-4.18%

ROE(5y)-1.98%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.97%

GM growth 5Y-1.86%

F-Score4

Asset Turnover0.73

Health

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	2.92
Debt/EBITDA	6.67
Cap/Depr	146.62%
Cap/Sales	13.81%
Interest Coverage	N/A
Cash Conversion	915.14%
Profit Quality	N/A
Current Ratio	7.42
Quick Ratio	2.75
Altman-Z	2.05

F-Score4

WACC6.72%

ROIC/WACCN/A

Cap/Depr(3y)170.7%

Cap/Depr(5y)144.35%

Cap/Sales(3y)15.86%

Cap/Sales(5y)13.92%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-113.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%24.75%

EPS Next Y23.88%

EPS Next 2Y31.58%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)4.93%

Revenue growth 3Y4.71%

Revenue growth 5Y0.88%

Sales Q2Q%12.48%

Revenue Next Year8.25%

Revenue Next 2Y14.73%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-108.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year183.78%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y147.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y286.44%

OCF growth 3YN/A

OCF growth 5Y17.1%

IBU-TEC ADVANCED MATERIALS A (IBU.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens